Page 1 of 13
Science for the final mile: Researchers gather to shape the future of polio eradication
For more than half a century, scientific discovery has helped protect millions of children from one of the world’s most feared diseases. Today, as the world stands closer than ever to eradicating polio, researchers continue to push the boundaries of innovation—not for the sake of science itself, but to ensure that every child, everywhere, can grow up free from the threat of polio
Tags: Polio
July 23, 2026
PharmaJet Instructions for Use: Previous Versions
PharmaJet Instructions for Use: Previous Versions Stratis 2013-July_60-10285A_Stratis_IFU.pdf 2017-Mar_60-10285-001B_Stratis_IFU.pdf 2017-Mar_60-10285-001C_Stratis_IFU.pdf 2019-Nov_60-10285-001E_Stratis_IFU.pdf Tropis 2016-Sept_60-10404-001A_Tropis_IFU.pdf 2017-Mar_60-10404-001B_Tropis_IFU.pdf 2018-Nov_60-10404-001C_Tropis_IFU.pdf 2018-Nov_60-10404-001D_Tropis_IFU.pdf 2019-Nov_60-10404-001E_Tropis_IFU.pdf 2020-Oct_60-10404-001F_Tropis_IFU.pdf 2021-Jan_60-10404-001G_Tropis_IFU.pdf 2021-Mar_60-10404-001H_Tropis_IFU.pdf 2021-July_60-10404-001J_Tropis_IFU.pdf 2022-Jan_60-10404-001K_Tropis_IFU.pdf 2023-Sep_60-10404-001L_Tropis_IFU.pdf Download Adobe Acrobat Reader
July 20, 2026
Site Disclaimer
Site Disclaimer This Site is Not a Source of Medical Advice The Content of this Site is provided for informational purposes only; it is not intended nor recommended as a substitute for professional medical advice. You should not use the Content of this Site for diagnosing a health or fitness problem or disease. Always seek...
July 1, 2026
Privacy Statement (AU)
Privacy Statement Additional Privacy Information This site and all of the contents therein are the exclusive property of PharmaJet, Inc. The purpose of this site is to provide information about PharmaJet, our mission, our products, and our future plans. We reserve the right to alter, change or delete any material from these pages at any...
June 28, 2026
Privacy Statement (ZA)
Privacy Statement Additional Privacy Information This site and all of the contents therein are the exclusive property of PharmaJet, Inc. The purpose of this site is to provide information about PharmaJet, our mission, our products, and our future plans. We reserve the right to alter, change or delete any material from these pages at any...
Privacy Statement (BR)
Privacy Statement Additional Privacy Information This site and all of the contents therein are the exclusive property of PharmaJet, Inc. The purpose of this site is to provide information about PharmaJet, our mission, our products, and our future plans. We reserve the right to alter, change or delete any material from these pages at any...
Privacy Statement (EU)
Privacy Statement Additional Privacy Information This site and all of the contents therein are the exclusive property of PharmaJet, Inc. The purpose of this site is to provide information about PharmaJet, our mission, our products, and our future plans. We reserve the right to alter, change or delete any material from these pages at any...
Privacy Statement (UK)
Privacy Statement Additional Privacy Information This site and all of the contents therein are the exclusive property of PharmaJet, Inc. The purpose of this site is to provide information about PharmaJet, our mission, our products, and our future plans. We reserve the right to alter, change or delete any material from these pages at any...
Privacy Statement (US)
Privacy Statement Additional Privacy Information This site and all of the contents therein are the exclusive property of PharmaJet, Inc. The purpose of this site is to provide information about PharmaJet, our mission, our products, and our future plans. We reserve the right to alter, change or delete any material from these pages at any...
Privacy Statement (CA)
Privacy Statement Additional Privacy Information This site and all of the contents therein are the exclusive property of PharmaJet, Inc. The purpose of this site is to provide information about PharmaJet, our mission, our products, and our future plans. We reserve the right to alter, change or delete any material from these pages at any...
Cookie Policy (BR)
Cookie Policy (BR)
Cookie Policy (EU)
Cookie Policy (EU)
Cookie Policy (UK)
Cookie Policy (UK)
Opt-out preferences
Opt Out Preferences
Cookie Policy (CA)
Cookie Policy (CA)
Cookie Policy (AU)
Cookie Policy (AU)
Cookie Policy (ZA)
Cookie Policy (ZA)
A Narrative Review and Perspective on Implementation Research on Intradermal Delivery Methods for Fractionated-Dose Inactivated Poliomyelitis Vaccine
Recent trends in intradermal (ID) vaccination, as seen in the Global Polio Eradication Initiative and in the 2022 monkeypox (mpox) pandemic, are a reminder that vaccine administration to the dermis is a valuable alternative to the traditional routes of parenteral delivery.
May 13, 2026
Published Review Highlights Advantages of Needle-free Intradermal Delivery Over Traditional Needle and Syringe
GOLDEN, Colo. — May 19, 2026 — A growing emphasis on dose-sparing strategies and equitable vaccine access has renewed global interest in ID vaccine delivery. A recent, peer-reviewed publication in Qeios¹ evaluated the evidence on implementation of novel technologies for ID delivery of fractional-dose inactivated polio vaccine (fIPV).
May 8, 2026
PharmaJet® Tropis® Needle-free Injection System Selected to Deliver 1.4 Million Polio Vaccine Doses in Nigeria
GOLDEN, Colo. — May 7, 2026 — PharmaJet, a global leader in needle-free injection technology, today announced that its WHO-prequalified Tropis ID Needle-free Injection System will be used to deliver approximately 1.4 million doses of fractional inactivated polio vaccine (fIPV) during upcoming polio immunization campaigns in Nigeria. PharmaJet is partnering with the African Field Epidemiology Network (AFENET), to deploy Tropis for fIPV delivery to children under 5 years of age in Sokoto, a state in northwestern Nigeria.
May 5, 2026
Page 1 of 13